Delivery Order SPE2DB24D2018-SPE2DB25FWWT7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,224.10 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a 90-count package. This competitive award, issued on August 11, 2025, with a completion date of August 12, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.29 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in quantities of 30, with a firm fixed price contract structure. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.29 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a 30-count package. This competitive award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role...
- The Defense Logistics Agency awarded a delivery order valued at $1,033.38 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This non-set-aside, firm fixed price delivery order was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets (90-count) under a firm fixed-price contract valued at $1,476.58. The order was competitively awarded without set-aside designation and is scheduled for completion by August 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a $7,598.76 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Letrozole 2.5 mg on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30 units, with a ceiling value of $4,624.30. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,116.30 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with a completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Letrozole 2.5 mg tablets (30-count units) with a ceiling value of $1,444.11. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and was awarded on a competitive basis without set-aside designation. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania—which serves as both the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units at a firm fixed price of $1,271.50. This is a non-set-aside competitively awarded contract with an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWT7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,906.52 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets (90-count units). This competitive award, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution center for federal medical procurement. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, AmerisourceBergen routinely supplies the Defense Health Agency and other government healthcare entities with brand-name and generic medications across multiple therapeutic domains. The award of this relatively modest delivery order exemplifies how the company leverages its prime IDC to fulfill ongoing pharmaceutical supply requirements for the Department of Defense medical supply chain on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/15/25 |